Shandong Lukang Pharmaceutical Co Ltd (600789) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.002x

Based on the latest financial reports, Shandong Lukang Pharmaceutical Co Ltd (600789) has a cash flow conversion efficiency ratio of -0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-6.39 Million ≈ $-935.75K USD) by net assets (CN¥4.10 Billion ≈ $600.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600789 net asset quality index to measure how much of total assets are equity-financed.

Shandong Lukang Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Shandong Lukang Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Shandong Lukang Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Shandong Lukang Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Lukang Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund NYSE:PTA	N/A
Changzhou NRB Corp SHE:002708	0.042x
Jingjin Environmental Protection Co Ltd SHG:603279	0.050x
Puuilo Oyj HE:PUUILO	0.214x
SUPERLOOP LTD F:9SL	N/A
Beijing Haitian Ruisheng Science Technology Ltd SHG:688787	0.019x
SKAN Group AG SW:SKAN	0.312x
Baota Industry Co Ltd SHE:000595	0.327x

Annual Cash Flow Conversion Efficiency for Shandong Lukang Pharmaceutical Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Shandong Lukang Pharmaceutical Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see 600789 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥5.26 Billion ≈ $769.21 Million	CN¥698.17 Million ≈ $102.16 Million	0.133x	+33.92%
2024-12-31	CN¥4.06 Billion ≈ $594.34 Million	CN¥402.82 Million ≈ $58.94 Million	0.099x	-38.57%
2023-12-31	CN¥3.74 Billion ≈ $547.48 Million	CN¥604.01 Million ≈ $88.39 Million	0.161x	+27.41%
2022-12-31	CN¥3.51 Billion ≈ $513.21 Million	CN¥444.38 Million ≈ $65.03 Million	0.127x	+188.43%
2021-12-31	CN¥3.40 Billion ≈ $497.41 Million	CN¥149.33 Million ≈ $21.85 Million	0.044x	-37.08%
2020-12-31	CN¥3.36 Billion ≈ $491.57 Million	CN¥234.55 Million ≈ $34.32 Million	0.070x	-38.80%
2019-12-31	CN¥3.17 Billion ≈ $464.11 Million	CN¥361.87 Million ≈ $52.95 Million	0.114x	-0.18%
2018-12-31	CN¥3.07 Billion ≈ $449.48 Million	CN¥351.09 Million ≈ $51.37 Million	0.114x	-12.93%
2017-12-31	CN¥2.10 Billion ≈ $307.12 Million	CN¥275.51 Million ≈ $40.32 Million	0.131x	-12.17%
2016-12-31	CN¥1.98 Billion ≈ $290.03 Million	CN¥296.23 Million ≈ $43.35 Million	0.149x	+263.29%
2015-12-31	CN¥1.91 Billion ≈ $278.80 Million	CN¥78.39 Million ≈ $11.47 Million	0.041x	-43.00%
2014-12-31	CN¥1.50 Billion ≈ $220.11 Million	CN¥108.56 Million ≈ $15.89 Million	0.072x	-54.00%
2013-12-31	CN¥1.63 Billion ≈ $239.22 Million	CN¥256.50 Million ≈ $37.53 Million	0.157x	+118.86%
2012-12-31	CN¥1.61 Billion ≈ $235.15 Million	CN¥115.20 Million ≈ $16.86 Million	0.072x	-1.52%
2011-12-31	CN¥1.69 Billion ≈ $247.82 Million	CN¥123.28 Million ≈ $18.04 Million	0.073x	-60.49%
2010-12-31	CN¥1.68 Billion ≈ $245.35 Million	CN¥308.88 Million ≈ $45.20 Million	0.184x	+42.96%
2009-12-31	CN¥1.55 Billion ≈ $226.53 Million	CN¥199.49 Million ≈ $29.19 Million	0.129x	-7.63%
2008-12-31	CN¥1.50 Billion ≈ $219.63 Million	CN¥209.39 Million ≈ $30.64 Million	0.140x	+48.39%
2007-12-31	CN¥1.46 Billion ≈ $213.69 Million	CN¥137.30 Million ≈ $20.09 Million	0.094x	+137.70%
2006-12-31	CN¥1.42 Billion ≈ $208.09 Million	CN¥56.24 Million ≈ $8.23 Million	0.040x	-63.33%
2005-12-31	CN¥1.50 Billion ≈ $219.27 Million	CN¥161.64 Million ≈ $23.65 Million	0.108x	+155.06%
2004-12-31	CN¥1.50 Billion ≈ $218.82 Million	CN¥63.24 Million ≈ $9.25 Million	0.042x	-59.21%
2003-12-31	CN¥1.61 Billion ≈ $236.31 Million	CN¥167.42 Million ≈ $24.50 Million	0.104x	-58.61%
2002-12-31	CN¥1.26 Billion ≈ $184.36 Million	CN¥315.59 Million ≈ $46.18 Million	0.250x	+7.61%
2001-12-31	CN¥1.16 Billion ≈ $170.00 Million	CN¥270.43 Million ≈ $39.57 Million	0.233x	+1077.05%
2000-12-31	CN¥1.13 Billion ≈ $165.42 Million	CN¥22.36 Million ≈ $3.27 Million	0.020x	-38.07%
1999-12-31	CN¥1.10 Billion ≈ $160.95 Million	CN¥35.12 Million ≈ $5.14 Million	0.032x	-22.53%
1998-12-31	CN¥1.12 Billion ≈ $163.93 Million	CN¥46.18 Million ≈ $6.76 Million	0.041x	--

About Shandong Lukang Pharmaceutical Co Ltd

SHG:600789 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.07 Billion

CN¥7.32 Billion CNY

Market Cap Rank

#8727 Global

#2144 in China

Share Price

CN¥7.00

Change (1 day)

+0.57%

52-Week Range

CN¥6.81 - CN¥10.91

All Time High

CN¥16.22